Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Domestic and urban violence faced by community health workers: a multidimensional analysis in vulnerable territories in northeastern Brazil during and after the COVID-19 pandemic.

Lancet regional health. Americas·2026
Same author

Perceptions of respectful maternity care in Ukraine during a time of war.

Journal of perinatal medicine·2025
Same author

Intersectionality and Intimate Partner Violence: Risk Factors and Vulnerabilities During the COVID-19 Pandemic and Other Humanitarian Emergencies.

Trauma, violence & abuse·2025
Same author

"You feel like you come up short over and over again": a qualitative study of provider perspectives of barriers to respectful maternity care in Boston.

Reproductive health·2025
Same author

Long-Term Results of a Phase 2 Study of Adjuvant Proton Radiation Therapy for Node-Positive Cancer of the Uterus and Cervix.

International journal of radiation oncology, biology, physics·2025
Same author

Monitoring surgical nociception using multisensor physiological models.

Proceedings of the National Academy of Sciences of the United States of America·2024

Related Experiment Video

Updated: Apr 8, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.5K

HPV testing as a screen for cervical cancer.

Annekathryn Goodman1

  • 1Division of Gynecologic Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA agoodman@partners.org.

BMJ (Clinical Research Ed.)
|July 2, 2015
PubMed
Summary

Human papillomavirus (HPV) is essential for cervical cancer. HPV testing effectively predicts cancer risk and aids early detection, especially in women in low-resource settings.

Area of Science:

  • Oncology
  • Virology
  • Public Health

Background:

  • Human papillomavirus (HPV) is a necessary cause of pre-invasive and invasive cancers of the lower genital tract.
  • Cervical cancer is the most prevalent HPV-related malignancy globally.
  • Advances in molecular understanding and epidemiology inform cancer detection and intervention strategies.

Purpose of the Study:

  • To review the current understanding of HPV-related diseases.
  • To examine the role of HPV testing in cervical cancer screening.
  • To synthesize evidence from diverse geographic and economic settings.

Main Methods:

  • Review of prospective and randomized controlled trials on HPV screening in Europe and North America.
  • Inclusion of data from smaller studies in low and middle-income countries.

More Related Videos

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K

Related Experiment Videos

Last Updated: Apr 8, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.5K
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K
  • Analysis of HPV testing for risk prediction of cervical cancer.

    • Main Results:

    • HPV testing identifies oncogenic subtypes capable of predicting future cervical cancer development.
    • Evidence from multiple regions supports the utility of HPV testing in screening protocols.
    • HPV screening is particularly relevant in areas where cervical cancer poses a significant burden.

    Conclusions:

    • HPV testing is a valuable tool for cervical cancer screening and risk stratification.
    • The integration of HPV testing into screening programs can improve early detection and intervention.
    • Further research and implementation are crucial, especially in resource-limited settings.